Albemarle - ALB Stock Forecast, Price & News

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View ALB analyst ratings or view top-rated stocks.

15 equities research analysts have issued twelve-month price objectives for Albemarle's shares. Their ALB share price forecasts range from $196.00 to $440.00. On average, they predict the company's stock price to reach $295.79 in the next twelve months. This suggests a possible upside of 8.5% from the stock's current price.
View analysts price targets for ALB or view top-rated stocks among Wall Street analysts.

Albemarle's stock was trading at $233.77 at the beginning of the year. Since then, ALB stock has increased by 16.6% and is now trading at $272.53.
View the best growth stocks for 2022 here.

Albemarle saw a increase in short interest in September. As of September 15th, there was short interest totaling 2,710,000 shares, an increase of 10.6% from the August 31st total of 2,450,000 shares. Based on an average daily volume of 1,280,000 shares, the short-interest ratio is presently 2.1 days.
View Albemarle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our ALB earnings forecast.

Albemarle will be holding an earnings conference call on Thursday, November 3rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 866-813-9403 with passcode "900408".

Albemarle Co. (NYSE:ALB) released its quarterly earnings results on Wednesday, August, 3rd. The specialty chemicals company reported $3.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.03 by $0.42. The specialty chemicals company earned $1.48 billion during the quarter, compared to analysts' expectations of $1.37 billion. Albemarle had a trailing twelve-month return on equity of 15.39% and a net margin of 6.08%. During the same period last year, the company earned $0.89 EPS.
Read the conference call transcript.

Albemarle announced a quarterly dividend on Monday, July 18th. Investors of record on Friday, September 16th will be paid a dividend of $0.395 per share on Monday, October 3rd. This represents a $1.58 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date of this dividend is Thursday, September 15th.
Read our dividend analysis for ALB.

Albemarle (NYSE:ALB) pays an annual dividend of $1.58 per share and currently has a dividend yield of 0.56%. The company has been increasing its dividend for 28 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 71.17%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 5.98% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

Albemarle updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $19.25-$22.25 for the period, compared to the consensus earnings per share estimate of $13.65. The company issued revenue guidance of $7.10 billion-$7.50 billion, compared to the consensus revenue estimate of $6.00 billion.

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include Mackenzie Financial Corp (0.02%), Gulf International Bank UK Ltd (0.02%), Red Spruce Capital LLC (0.01%), Capital Investment Advisors LLC (0.00%), AdvisorNet Financial Inc (0.00%) and Fulton Bank N.A. (0.00%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $272.53.

Albemarle (NYSE:ALB) has a market capitalization of $31.92 billion and generates $3.33 billion in revenue each year. The specialty chemicals company earns $123.67 million in net income (profit) each year or $2.22 on an earnings per share basis.

The company employs 6,000 workers across the globe.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The official website for the company is www.albemarle.com. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at invest@albemarle.com, or via fax at 225-388-7686.